Centre for Health Economics Research and Evaluation (CHERE)
PEOPLE
- Senior Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Senior Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Rebecca Addo is a Research Fellow at CHERE (Centre for Health Economics Research and Evaluation).
Her interest in the field of health economics began when she started working as a hospital nurse in Ghana.
“I realised that there were a lot of things we needed to work with on the ward that we didn’t have resources for,” Dr Addo said.
“There were also conditions that could be prevented before they got to hospital.”
This prompted her to complete her Master of Public Health degree from the University of Ghana, before coming to UTS in 2015 to complete a PhD in health economics.
Her PhD thesis focused on assessing the feasibility of a developing country (Ghana), constrained with human and data resources, to conduct and use Health Technology Assessment (HTA) for health decision making. Her thesis found that it was feasible for Ghana to conduct and use HTA in their health system when the identified barriers and challenges such as limited human and data capacity and lack of knowledge of HTA. The thesis also highlighted that limited data for HTA in Ghana, meant relying on international data in the short to medium term, however, these data need to be transformed to be context-specific before they are suitable for use in an economic evaluation.
Currently, Rebecca’s main research interests include, priority setting in health, HTA, and the application of HTA methods to health care decisions in developing countries and development and measurement of health outcomes.
She has skills in mixed research methods including economic modelling, systematic literature reviews, and stakeholder engagements through qualitative research methods.
In her current position, Rebecca is part of the Economic Evaluation team that critically appraises economic evaluations for the Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC). Rebecca conducts health technology assessment for the MSAC and other external bodies such as the Singapore Agency for Care Effectiveness. Rebecca also works with the Quality of Life team on the development and psychometric testing of health outcome measures such as EQ-5D-5L and its bolt-on descriptors. Her work in this area involves working with researchers internationally, in the UK and Ghana. In addition to research work, Rebecca teaches health economics subjects offered in the university.
“Companies submit data on a new drug, and we evaluate what has been presented for the Department of Health,” she said.
“We look at the data so see if the drug does what it does, models, the safety and effectiveness of the drug, whether the government should fund it and how much it will cost the government in the first six years.”
Previously, Rebecca has worked as a general nurse and as a lecturer in nursing and public health institutions located in Ghana, and as a tutor in health economics at UTS, Australia. Rebecca also has experience in teaching undergraduate and postgraduate students in public health, health economics, and nursing both in Ghana and Australia.Rebecca Addo is a Research Fellow at CHERE (Centre for Health Economics Research and Evaluation).
Her interest in the field of health economics began when she started working as a hospital nurse in Ghana.
“I realised that there were a lot of things we needed to work with on the ward that we didn’t have resources for,” Dr Addo said.
“There were also conditions that could be prevented before they got to hospital.”
This prompted her to complete her Master of Public Health degree from the University of Ghana, before coming to UTS in 2015 to complete a PhD in health economics.
Her PhD thesis focused on assessing the feasibility of a developing country (Ghana), constrained with human and data resources, to conduct and use Health Technology Assessment (HTA) for health decision making. Her thesis found that it was feasible for Ghana to conduct and use HTA in their health system when the identified barriers and challenges such as limited human and data capacity and lack of knowledge of HTA. The thesis also highlighted that limited data for HTA in Ghana, meant relying on international data in the short to medium term, however, these data need to be transformed to be context-specific before they are suitable for use in an economic evaluation.
Currently, Rebecca’s main research interests include, priority setting in health, HTA, and the application of HTA methods to health care decisions in developing countries and development and measurement of health outcomes.
She has skills in mixed research methods including economic modelling, systematic literature reviews, and stakeholder engagements through qualitative research methods.
In her current position, Rebecca is part of the Economic Evaluation team that critically appraises economic evaluations for the Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC). Rebecca conducts health technology assessment for the MSAC and other external bodies such as the Singapore Agency for Care Effectiveness. Rebecca also works with the Quality of Life team on the development and psychometric testing of health outcome measures such as EQ-5D-5L and its bolt-on descriptors. Her work in this area involves working with researchers internationally, in the UK and Ghana. In addition to research work, Rebecca teaches health economics subjects offered in the university.
“Companies submit data on a new drug, and we evaluate what has been presented for the Department of Health,” she said.
“We look at the data so see if the drug does what it does, models, the safety and effectiveness of the drug, whether the government should fund it and how much it will cost the government in the first six years.”
Previously, Rebecca has worked as a general nurse and as a lecturer in nursing and public health institutions located in Ghana, and as a tutor in health economics at UTS, Australia. Rebecca also has experience in teaching undergraduate and postgraduate students in public health, health economics, and nursing both in Ghana and Australia.- Academic
- Collaborative projects
- Masters Research or PhD student supervision
- Membership of an advisory committee
- Mentoring (short-term)
Disciplines- Applied economics
- Public health
- Graduate Research Student
- INSIGHT Cntr for Health Economics Research & Evaluation
- Graduate Research StudentINSIGHT Cntr for Health Economics Research & Evaluation
- Higher Degree by Research
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
I have a keen interest in health economic evaluation, decision modelling and equity considerations. I have participated in several research projects’ health economic evaluations using within-trial analysis, decision-analytic modelling, systematic reviews and value of information analysis. I also evaluate submissions to the Pharmaceutical Benefits Advisory Committee as well as conduct work for the Medical Services Advisory Committee.I have a keen interest in health economic evaluation, decision modelling and equity considerations. I have participated in several research projects’ health economic evaluations using within-trial analysis, decision-analytic modelling, systematic reviews and value of information analysis. I also evaluate submissions to the Pharmaceutical Benefits Advisory Committee as well as conduct work for the Medical Services Advisory Committee.- Academic
- Collaborative projects
- Masters Research or PhD student supervision
- Membership of an advisory committee
Disciplines- Health economics
- Health equity
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
- Academic
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
- Academic
Disciplines- Applied economics
- Senior Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Senior Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Dr Sheena Arora is a Senior Research Fellow at the Centre for Health Economics Research and Evaluation (CHERE) at the University of Technology Sydney.
She is a health economist with expertise in applied economic evaluation focusing on child and caregiver health.
Her work involves two areas:
• Health Technology Assessment –considerable experience in the economic evaluation of pharmaceutical products and medical devices through her work as senior evaluator for the Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee.
• Research – with a focus on economic evaluations of psychosocial interventions in children and individuals with a disability. She is also involved as a health economist in a study evaluating a nurse-led intervention for survivors of childhood brain cancer.
Her PhD explored the economic implications of childhood intellectual disability.
She has considerable experience working with large-scale studies and has been involved in the design and implementation of trial based economic evaluations, including the design of data collection instruments, the application of linked data, costing of programs and evaluation of outcome data.
She has conducted complex economic data analyses using advanced statistical methods, including the use of panel data techniques and the design and analysis of discrete choice experiments.
“My family has many doctors, and I had an early interest in health and nutrition, so health economics became an obvious choice,” she said.Dr Sheena Arora is a Senior Research Fellow at the Centre for Health Economics Research and Evaluation (CHERE) at the University of Technology Sydney.
She is a health economist with expertise in applied economic evaluation focusing on child and caregiver health.
Her work involves two areas:
• Health Technology Assessment –considerable experience in the economic evaluation of pharmaceutical products and medical devices through her work as senior evaluator for the Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee.
• Research – with a focus on economic evaluations of psychosocial interventions in children and individuals with a disability. She is also involved as a health economist in a study evaluating a nurse-led intervention for survivors of childhood brain cancer.
Her PhD explored the economic implications of childhood intellectual disability.
She has considerable experience working with large-scale studies and has been involved in the design and implementation of trial based economic evaluations, including the design of data collection instruments, the application of linked data, costing of programs and evaluation of outcome data.
She has conducted complex economic data analyses using advanced statistical methods, including the use of panel data techniques and the design and analysis of discrete choice experiments.
“My family has many doctors, and I had an early interest in health and nutrition, so health economics became an obvious choice,” she said.- Academic
- Masters Research or PhD student supervision
Disciplines- Applied economics
- Public health
- Professor
- INSIGHT Cntr for Health Economics Research & Evaluation
- ProfessorINSIGHT Cntr for Health Economics Research & Evaluation
Daniel is a Professor at the Centre for Health Economics Research and Evaluation (CHERE) at UTS and an internationally acclaimed leader in the fields of health economics, applied econometrics, and policy analysis. He holds a PhD from Uppsala University and has previously held roles at the Department of Economics, Deakin University, and at the Centre for Health Economics, Monash University. Daniel's research interests comprise empirical analysis of topics relating to the production, financing and organisation of health care. He has more than 15 years’ experience of analysing administrative and clinical data from Sweden, Germany, and Australia.Daniel has a strong track record of influential publications in leading journals in economics and successful research funding applications both in Australia and overseas. His research has appeared in leading general interest economics journals, including the American Economic Journal: Applied Economics, American Economic Journal: Economic Policy and the European Economic Review, and top field journals, such as the Journal of Health Economics, the Journal of Public Economics and the Journal of Applied Econometrics. He is a named investigator in three recent (2022, 2024, 2025) successful Discovery grants from the Australian Research Council and has attracted approximately $7m in research grants over his career. Daniel is currently an associate editor of the Journal of Health Economics and the European Journal of Health Economics, both leading field journals in health economics, and has more than ten years of experience in teaching applied econometric methods on all academic levels. Daniel was recently awarded the Vice-chancellor’s Mid-Career Researcher Award for Career Excellence from Deakin University and a science award from the German Health Economics Association.
Daniel is an expert on economic modelling, causal inference, and policy evaluation on a wide range of topics relating to health and social care functionality. He recently led an ARC Discovery grant on physician preferences for medical innovations to explore the effects of technological diffusion, substitution and adoption of new medical technology on quality of care. Daniel is currently leading a project funded by the Commonwealth Department of Health, Disability, and Ageing to understand the causal link between government spending on health and productivity and is a co-lead on a Digital Health CRC commissioned project evaluating the impact of an AI enabled virtual care model in aged care.
Daniel is a Professor at the Centre for Health Economics Research and Evaluation (CHERE) at UTS and an internationally acclaimed leader in the fields of health economics, applied econometrics, and policy analysis. He holds a PhD from Uppsala University and has previously held roles at the Department of Economics, Deakin University, and at the Centre for Health Economics, Monash University. Daniel's research interests comprise empirical analysis of topics relating to the production, financing and organisation of health care. He has more than 15 years’ experience of analysing administrative and clinical data from Sweden, Germany, and Australia.Daniel has a strong track record of influential publications in leading journals in economics and successful research funding applications both in Australia and overseas. His research has appeared in leading general interest economics journals, including the American Economic Journal: Applied Economics, American Economic Journal: Economic Policy and the European Economic Review, and top field journals, such as the Journal of Health Economics, the Journal of Public Economics and the Journal of Applied Econometrics. He is a named investigator in three recent (2022, 2024, 2025) successful Discovery grants from the Australian Research Council and has attracted approximately $7m in research grants over his career. Daniel is currently an associate editor of the Journal of Health Economics and the European Journal of Health Economics, both leading field journals in health economics, and has more than ten years of experience in teaching applied econometric methods on all academic levels. Daniel was recently awarded the Vice-chancellor’s Mid-Career Researcher Award for Career Excellence from Deakin University and a science award from the German Health Economics Association.
Daniel is an expert on economic modelling, causal inference, and policy evaluation on a wide range of topics relating to health and social care functionality. He recently led an ARC Discovery grant on physician preferences for medical innovations to explore the effects of technological diffusion, substitution and adoption of new medical technology on quality of care. Daniel is currently leading a project funded by the Commonwealth Department of Health, Disability, and Ageing to understand the causal link between government spending on health and productivity and is a co-lead on a Digital Health CRC commissioned project evaluating the impact of an AI enabled virtual care model in aged care.
- Academic
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Mina is a Research Fellow at CHERE, she joined the Centre in October 2021. Prior to joining CHERE, she worked at the Centre for Applied Health Economics as a Research Fellow with the health economics team. Mina holds a Ph.D. in Health Economics from Griffith University.
She has developed a condition-specific measure to be used in the assessment of health interventions for people with Cerebral Palsy. She has experience in using psychometric and valuation methods such as Factor analysis and Discrete Choice Experiments. Her research interests are eliciting preferences, valuation and measuring the quality of life.Mina is a Research Fellow at CHERE, she joined the Centre in October 2021. Prior to joining CHERE, she worked at the Centre for Applied Health Economics as a Research Fellow with the health economics team. Mina holds a Ph.D. in Health Economics from Griffith University.
She has developed a condition-specific measure to be used in the assessment of health interventions for people with Cerebral Palsy. She has experience in using psychometric and valuation methods such as Factor analysis and Discrete Choice Experiments. Her research interests are eliciting preferences, valuation and measuring the quality of life.- Academic
- Collaborative projects
- Masters Research or PhD student supervision
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Mark is a Research Fellow with the Centre for Health Economics Research and Evaluation and currently works as an Evaluator within the HTA team. Mark is a health economist who has spent the last 4 years working in the field of pharmaceutical market access and reimbursement in Australia and Europe. Most recently, he spent two years with Biointelect, a life science consultancy, working as a consultant within the strategic market access and policy team. This work involved working with a wide range of stakeholders across the life science industry including multinational pharmaceutical companies, universities, government organisations, and more.
Mark has a keen interest in several therapeutic areas such as infectious disease, overweight and obesity, oncology and rare disease. His primary focus is on optimising healthcare delivery, with an emphasis on value and equitable access. He is also particularly interested in the health technology assessment of new interventions.
Before moving to Australia and joining Biointelect, Mark spent two years in Health Economics & Outcome Research roles at Novartis Pharmaceuticals. He began his career as a pharmacist, working in both hospital and community settings before deciding to pursue Health Economics. Mark holds a MPharm from the University of Brighton (UoB) and a MSc in Health Economics from the National University of Ireland, Galway (NUIG).
Mark is a Research Fellow with the Centre for Health Economics Research and Evaluation and currently works as an Evaluator within the HTA team. Mark is a health economist who has spent the last 4 years working in the field of pharmaceutical market access and reimbursement in Australia and Europe. Most recently, he spent two years with Biointelect, a life science consultancy, working as a consultant within the strategic market access and policy team. This work involved working with a wide range of stakeholders across the life science industry including multinational pharmaceutical companies, universities, government organisations, and more.
Mark has a keen interest in several therapeutic areas such as infectious disease, overweight and obesity, oncology and rare disease. His primary focus is on optimising healthcare delivery, with an emphasis on value and equitable access. He is also particularly interested in the health technology assessment of new interventions.
Before moving to Australia and joining Biointelect, Mark spent two years in Health Economics & Outcome Research roles at Novartis Pharmaceuticals. He began his career as a pharmacist, working in both hospital and community settings before deciding to pursue Health Economics. Mark holds a MPharm from the University of Brighton (UoB) and a MSc in Health Economics from the National University of Ireland, Galway (NUIG).
- Academic
- Career advice
- Collaborative projects
- Industry Projects
Disciplines- Health economics
- Applied economics
- Senior Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Senior Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Dr Jody Church is a Research Fellow at CHERE. Jody is an experienced researcher in health economics and has a demonstrated track record as an evaluator for the Pharmaceutical and Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC). She has conducted numerous economic evaluations in a variety of medical conditions, including falls prevention, smoking cessation, hearing loss, esophageal cancer, colonic stents and cardiac disease. She also has experience in conducting systematic reviews and meta-analyses. Prior to CHERE, Jody worked at the OECD on projects about medical workforce migration and obesity. Most recently Jody has focused her research on the economics of obesity, including involvement in discrete choice experimental design and implementation. This research has also involved the use and understanding of longitudinal datasets and econometric analysis techniques. Jody is also currently conducting multiple DCEs for the Health Economics working group of a NHMRC funded research program focusing on preconception care, contraception, and medical abortion. Jody’s research interests are in discrete choice experiments, health technology assessment and applied econometrics.Dr Jody Church is a Research Fellow at CHERE. Jody is an experienced researcher in health economics and has a demonstrated track record as an evaluator for the Pharmaceutical and Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC). She has conducted numerous economic evaluations in a variety of medical conditions, including falls prevention, smoking cessation, hearing loss, esophageal cancer, colonic stents and cardiac disease. She also has experience in conducting systematic reviews and meta-analyses. Prior to CHERE, Jody worked at the OECD on projects about medical workforce migration and obesity. Most recently Jody has focused her research on the economics of obesity, including involvement in discrete choice experimental design and implementation. This research has also involved the use and understanding of longitudinal datasets and econometric analysis techniques. Jody is also currently conducting multiple DCEs for the Health Economics working group of a NHMRC funded research program focusing on preconception care, contraception, and medical abortion. Jody’s research interests are in discrete choice experiments, health technology assessment and applied econometrics.- Academic
Disciplines- Applied economics
- Public health
- Health Economist
- INSIGHT Cntr for Health Economics Research & Evaluation
- Health EconomistINSIGHT Cntr for Health Economics Research & Evaluation
Paula Cronin is a health service researcher and health economist at the Centre for Health Economics Research and Evaluation (CHERE) where she has been employed as a part-time Research Fellow since 2006. During this time, she has worked largely in the Economic Evaluation team. Paula main research interest is in the economics of childhood. In 2018, she completed her PhD in health economics at UTS. The title of her thesis was 'The Economic Impact of Childhood Developmental Language Disorder'. Paula also has a Bachelor of Science and a Masters of Public Health .
Paula is a member of the Cancer Research Economics Support Team (CREST), which is national cancer-focussed health economics service funded by Cancer Australia as part of their Support for Clinical Trials program. She is an invited member of the Medical Services Advisory Committee Evaluation sub-committee (2017-2020). This role involves evaluating applications for new medical services to be funded on the MBS, which directly impacts national health policy. In 2012, she was an invited panel member for the Pharmaceutical Benefits Cost Recovery Review for the Commonwealth Department of Health. The conclusions of this review were used to inform pharmaceutical benefits reforms.Paula Cronin is a health service researcher and health economist at the Centre for Health Economics Research and Evaluation (CHERE) where she has been employed as a part-time Research Fellow since 2006. During this time, she has worked largely in the Economic Evaluation team. Paula main research interest is in the economics of childhood. In 2018, she completed her PhD in health economics at UTS. The title of her thesis was 'The Economic Impact of Childhood Developmental Language Disorder'. Paula also has a Bachelor of Science and a Masters of Public Health .
Paula is a member of the Cancer Research Economics Support Team (CREST), which is national cancer-focussed health economics service funded by Cancer Australia as part of their Support for Clinical Trials program. She is an invited member of the Medical Services Advisory Committee Evaluation sub-committee (2017-2020). This role involves evaluating applications for new medical services to be funded on the MBS, which directly impacts national health policy. In 2012, she was an invited panel member for the Pharmaceutical Benefits Cost Recovery Review for the Commonwealth Department of Health. The conclusions of this review were used to inform pharmaceutical benefits reforms.- Academic
- Masters Research or PhD student supervision
Disciplines- Applied economics
- Public health
- Professor
- INSIGHT Cntr for Health Economics Research & Evaluation
- ProfessorINSIGHT Cntr for Health Economics Research & Evaluation
Richard is a Professor with the Centre for Health Economics Research and Evaluation. He is currently working as the Senior Evaluator for the PBAC Team and as the Project Officer/Coordinator for the Cancer Research Economics Support Team (CREST). Richard is a very experienced health economist who has spent the last 12 years working in the field of market access and reimbursement for pharmaceuticals and medical devices in Australia. Most recently, this included seven years with Covance, a clinical research organisation, as a Director of Health Economics. This work has involved liaison with multiple stakeholders throughout the treatment development pathway including clinical trialists, clinicians, patients and patient support networks, statisticians and the reimbursement authorities.
He has a keen interest in applied economic evaluations, the economics of specialty health areas, patient preference and quality of life, and priority setting. Richard's primary interest and focus in specialty health has been in the fields of oncology/haematology, across a broad range of indications and clinical settings. Prior to joining Covance, he spent five years as a member of the health economics team at Novartis Pharmaceuticals, and prior to that four years CHERE.
He commenced his career as an Economist with the Reserve Bank of Australia. He holds an MEc (Hons) from Sydney University, and a BEc (Hons) from Murdoch University and PhD from UTS.Richard is a Professor with the Centre for Health Economics Research and Evaluation. He is currently working as the Senior Evaluator for the PBAC Team and as the Project Officer/Coordinator for the Cancer Research Economics Support Team (CREST). Richard is a very experienced health economist who has spent the last 12 years working in the field of market access and reimbursement for pharmaceuticals and medical devices in Australia. Most recently, this included seven years with Covance, a clinical research organisation, as a Director of Health Economics. This work has involved liaison with multiple stakeholders throughout the treatment development pathway including clinical trialists, clinicians, patients and patient support networks, statisticians and the reimbursement authorities.
He has a keen interest in applied economic evaluations, the economics of specialty health areas, patient preference and quality of life, and priority setting. Richard's primary interest and focus in specialty health has been in the fields of oncology/haematology, across a broad range of indications and clinical settings. Prior to joining Covance, he spent five years as a member of the health economics team at Novartis Pharmaceuticals, and prior to that four years CHERE.
He commenced his career as an Economist with the Reserve Bank of Australia. He holds an MEc (Hons) from Sydney University, and a BEc (Hons) from Murdoch University and PhD from UTS.- Academic
- Masters Research or PhD student supervision
Disciplines- Applied economics
- Public health
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Rafael de Feria is a research fellow at the Centre for Health Economics Research and Evaluation (CHERE). He holds a master’s degree in health economics and Pharmacoeconomics from Universitat Pompeu Fabra and a PhD in Health Economics from the University of Technology Sydney.
Rafael provides support in evaluating various methods used in pharmaceutical and medical device submissions submitted to government bodies, including the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) in Australia, as well as the Agency for Care Effectiveness (ACE) in Singapore. He is experienced in a range of methodologies, including decision analytical modelling in healthcare, survival analysis and meta-analysis. Rafael has particular expertise in surrogate outcomes and their incorporation into economic models. His research focuses on improving the integration of these intermediate endpoints into health economic evaluations, enhancing the accuracy and reliability of cost-effectiveness analyses. In addition to his academic work, Rafael is an AI enthusiast, actively exploring how it can be leveraged to transform decision-making processes in healthcare economics and policy.
Rafael de Feria is a research fellow at the Centre for Health Economics Research and Evaluation (CHERE). He holds a master’s degree in health economics and Pharmacoeconomics from Universitat Pompeu Fabra and a PhD in Health Economics from the University of Technology Sydney.
Rafael provides support in evaluating various methods used in pharmaceutical and medical device submissions submitted to government bodies, including the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) in Australia, as well as the Agency for Care Effectiveness (ACE) in Singapore. He is experienced in a range of methodologies, including decision analytical modelling in healthcare, survival analysis and meta-analysis. Rafael has particular expertise in surrogate outcomes and their incorporation into economic models. His research focuses on improving the integration of these intermediate endpoints into health economic evaluations, enhancing the accuracy and reliability of cost-effectiveness analyses. In addition to his academic work, Rafael is an AI enthusiast, actively exploring how it can be leveraged to transform decision-making processes in healthcare economics and policy.
- Academic
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
- 8 Decent Work and Economic Growth
- Academic
- Masters Research or PhD student supervision
- Collaborative projects
- Industry Projects
- Mentoring (short-term)
- Teaching provision
Disciplines- Applied economics
- Professor
- INSIGHT Cntr for Health Economics Research & Evaluation
- ProfessorINSIGHT Cntr for Health Economics Research & Evaluation
Stephen is a Health Economist and a Deputy Director of CHERE. He is also the manager of the economic evaluation research group. This role involves managing a group of health economists, and liaising, negotiating contracts and completing reports with commissioning agencies. His main areas of interest are; economic evaluation of health technologies, public health, primary care, access to health care and equity.
He also provides postgraduate lectures on topics aligned with his research (to date: "Introduction to Health Economics" and "Planning and Evaluating Health Services"). Stephen completed a Master of Health Economics from the University of York. His thesis, an econometric analysis of the HILDA (a large panel) dataset, titled "Is hospital treatment in Australia equitable?" was undertaken at the University of Melbourne. He has a PhD in Vascular Medicine from the University of Leicester, which focused on health services research.
Prior to joining CHERE Stephen worked for 7 years within clinical development, where he helped design and managed national and international randomised clinical trials. He was also responsible for training and supervising medical colleagues during their research sabbatical. He spent two years in the Pharmaceutical Industry. At the University of Bristol he managed a large multi-centred UK Government sponsored evaluation of access to primary care.
His work has led to numerous peer reviewed journal articles and conference presentations, as well as several commissioned reports.Stephen is a Health Economist and a Deputy Director of CHERE. He is also the manager of the economic evaluation research group. This role involves managing a group of health economists, and liaising, negotiating contracts and completing reports with commissioning agencies. His main areas of interest are; economic evaluation of health technologies, public health, primary care, access to health care and equity.
He also provides postgraduate lectures on topics aligned with his research (to date: "Introduction to Health Economics" and "Planning and Evaluating Health Services"). Stephen completed a Master of Health Economics from the University of York. His thesis, an econometric analysis of the HILDA (a large panel) dataset, titled "Is hospital treatment in Australia equitable?" was undertaken at the University of Melbourne. He has a PhD in Vascular Medicine from the University of Leicester, which focused on health services research.
Prior to joining CHERE Stephen worked for 7 years within clinical development, where he helped design and managed national and international randomised clinical trials. He was also responsible for training and supervising medical colleagues during their research sabbatical. He spent two years in the Pharmaceutical Industry. At the University of Bristol he managed a large multi-centred UK Government sponsored evaluation of access to primary care.
His work has led to numerous peer reviewed journal articles and conference presentations, as well as several commissioned reports.- Academic
Disciplines- Applied economics
- Public health
- Emeritus Professor
- The Dean's Unit
- Emeritus ProfessorThe Dean's Unit
Marion is Professor of Health Economics at CHERE. Formerly a physiotherapist, she has a Masters of Public Health (University of Sydney), a Graduate Diploma of Applied Epidemiology (NSW Health) and a PhD (University of Sydney). A leading health services researcher for many years, Marion has extensive policy and research based experience of health services funding and financing in Australia.
Her research interests are in the application of economic analysis to policy and practice; planning and evaluating health services; incorporating health economics into health services research, including clinical trials; the application of discrete choice methods to consumer preferences in health; and understanding the impact of health policy on access to, utilisation and costs of health care services.
She is currently a chief investigator on a number of major NHMRC grants, including a CRE in Women's Sexual and Reproductive Health (SPHERE). Between 2010 and 2017, Marion was one of the leaders of the Cancer Research Economics Research Team (CREST) at CHERE. She is an honorary life member of the Health Services Research Association of Australia and New Zealand.Marion is Professor of Health Economics at CHERE. Formerly a physiotherapist, she has a Masters of Public Health (University of Sydney), a Graduate Diploma of Applied Epidemiology (NSW Health) and a PhD (University of Sydney). A leading health services researcher for many years, Marion has extensive policy and research based experience of health services funding and financing in Australia.
Her research interests are in the application of economic analysis to policy and practice; planning and evaluating health services; incorporating health economics into health services research, including clinical trials; the application of discrete choice methods to consumer preferences in health; and understanding the impact of health policy on access to, utilisation and costs of health care services.
She is currently a chief investigator on a number of major NHMRC grants, including a CRE in Women's Sexual and Reproductive Health (SPHERE). Between 2010 and 2017, Marion was one of the leaders of the Cancer Research Economics Research Team (CREST) at CHERE. She is an honorary life member of the Health Services Research Association of Australia and New Zealand.- Academic
- Masters Research or PhD student supervision
Disciplines- Applied economics
- Public health
- Senior Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Senior Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Prior to starting at CHERE, Kate was Associate Director of Health Economics (2023-2024) and Senior Health Outcomes Associate (2015-2023) at SYNEVi, an independent consultancy providing services in market access, health economics, health outcomes and pricing to the healthcare industry. Kate also worked as a Health Outcomes Analyst at PRIMA Consulting (2012-2015). Her last research position was as Postdoctoral Researcher at The Heart Research Institute, Sydney (2009-2012). Throughout her work Kate has demonstrated a strong commitment to achieving access to health care for Australian patients. Kate has a Masters in Health Economics (Deakin University, 2019) and completed her PhD in Reproductive Immunology through the University of Sydney at the Kolling Institute of Medical Research (2009). She completed a Bachelor of Medical Science (2003) with Honours (2004) through the University of Technology, Sydney.
Prior to starting at CHERE, Kate was Associate Director of Health Economics (2023-2024) and Senior Health Outcomes Associate (2015-2023) at SYNEVi, an independent consultancy providing services in market access, health economics, health outcomes and pricing to the healthcare industry. Kate also worked as a Health Outcomes Analyst at PRIMA Consulting (2012-2015). Her last research position was as Postdoctoral Researcher at The Heart Research Institute, Sydney (2009-2012). Throughout her work Kate has demonstrated a strong commitment to achieving access to health care for Australian patients. Kate has a Masters in Health Economics (Deakin University, 2019) and completed her PhD in Reproductive Immunology through the University of Sydney at the Kolling Institute of Medical Research (2009). She completed a Bachelor of Medical Science (2003) with Honours (2004) through the University of Technology, Sydney.
- Academic
- Adjunct Professor
- INSIGHT Cntr for Health Economics Research & Evaluation
- Adjunct ProfessorINSIGHT Cntr for Health Economics Research & Evaluation
Jane Hall was made an Officer in the Order of Australia (AO) in 2023 for services to the social sciences, particularly health economics, and the development of professional associations. She is Distinguished Professor of Health Economics in the UTS Centre for Health Economics Research and Evaluation, a Fellow of the Academy of Social Sciences in Australia, and a Fellow of the Australian Academy of Health and Medical Sciences. Her current work is focussed on the financing and funding of health care to improve system performance.
She is a member of the Independent Health and Aged Care Pricing Authority.
Over her career, she has worked across many areas of health economics, including health technology assessment, measurement of quality of life, end of life care, health workforce, and the economics of primary care. She has been involved in health policy issues nationally and internationally, and internationally has been an active member of numerous committees and working parties. She has had a long involvement with the Commonwealth Fund International Program in Health Policy and Practice and served on the Harkness Fellowship Selection Committee for many years.
Jane was the founding Director of CHERE which was established in 1990 on her initiative; and held that position until 2012. She is a Past President of the Academy of Social Sciences in Australia, the Health Services Research Association of Australia and New Zealand and the International Health Economics Association. Among her recognition and honours are UTS Distinguished Service Award (2019); the National Health and Medical Research Council Outstanding Contribution Award (2017); Australian Financial Review/Westpac 100 Women of Influence (2016); the inaugural Professional Award of the Health Services Research Association of Australia and New Zealand (2011).Jane Hall was made an Officer in the Order of Australia (AO) in 2023 for services to the social sciences, particularly health economics, and the development of professional associations. She is Distinguished Professor of Health Economics in the UTS Centre for Health Economics Research and Evaluation, a Fellow of the Academy of Social Sciences in Australia, and a Fellow of the Australian Academy of Health and Medical Sciences. Her current work is focussed on the financing and funding of health care to improve system performance.
She is a member of the Independent Health and Aged Care Pricing Authority.
Over her career, she has worked across many areas of health economics, including health technology assessment, measurement of quality of life, end of life care, health workforce, and the economics of primary care. She has been involved in health policy issues nationally and internationally, and internationally has been an active member of numerous committees and working parties. She has had a long involvement with the Commonwealth Fund International Program in Health Policy and Practice and served on the Harkness Fellowship Selection Committee for many years.
Jane was the founding Director of CHERE which was established in 1990 on her initiative; and held that position until 2012. She is a Past President of the Academy of Social Sciences in Australia, the Health Services Research Association of Australia and New Zealand and the International Health Economics Association. Among her recognition and honours are UTS Distinguished Service Award (2019); the National Health and Medical Research Council Outstanding Contribution Award (2017); Australian Financial Review/Westpac 100 Women of Influence (2016); the inaugural Professional Award of the Health Services Research Association of Australia and New Zealand (2011).- Academic
- Media enquiries
- Collaborative projects
Disciplines- Applied economics
- Public health
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Lutfun Hossain is a Research Fellow at CHERE. She is a health services researcher and aims to further develop her academic career in health economics, applied microeconometrics and health policy research.
Lutfun started her career as a pharmacist working in both a community and hospital setting. She completed a Master of Pharmacy (Research) at the University of Technology Sydney where she explored factors that influence the implementation of health services in a community pharmacy setting. During this time, she was involved in teaching students, was a recipient of the UTS Chancellor’s Research Scholarship, published scientific publications in peer-reviewed journals and presented abstracts at several international conferences. During her research Lutfun also collaborated with experts at the Institute for Sustainable Futures, the Western Sydney Primary Health Network and the University of Lisbon.
Prior to CHERE, Lutfun worked as a clinical product specialist at NPS MedicineWise where she collaborated with internal and external stakeholders (e.g., clinical experts, the Department of Human Services and scientific organisations) to contribute to the development of national programs to improve the quality use of medicines and medical tests. She designed audit and feedback products for GPs and Pharmacists and has extensive experience in working with PBS, MBS and MedicineInsight data.Lutfun Hossain is a Research Fellow at CHERE. She is a health services researcher and aims to further develop her academic career in health economics, applied microeconometrics and health policy research.
Lutfun started her career as a pharmacist working in both a community and hospital setting. She completed a Master of Pharmacy (Research) at the University of Technology Sydney where she explored factors that influence the implementation of health services in a community pharmacy setting. During this time, she was involved in teaching students, was a recipient of the UTS Chancellor’s Research Scholarship, published scientific publications in peer-reviewed journals and presented abstracts at several international conferences. During her research Lutfun also collaborated with experts at the Institute for Sustainable Futures, the Western Sydney Primary Health Network and the University of Lisbon.
Prior to CHERE, Lutfun worked as a clinical product specialist at NPS MedicineWise where she collaborated with internal and external stakeholders (e.g., clinical experts, the Department of Human Services and scientific organisations) to contribute to the development of national programs to improve the quality use of medicines and medical tests. She designed audit and feedback products for GPs and Pharmacists and has extensive experience in working with PBS, MBS and MedicineInsight data.- Academic
Disciplines- Applied economics
- Public health
- Visiting Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Visiting FellowINSIGHT Cntr for Health Economics Research & Evaluation
- Academic
- Adjunct Associate Professor
- INSIGHT IMPACCT
- Adjunct Associate ProfessorINSIGHT IMPACCT
Irina is a Senior Research Fellow (honorary) with a joint appointment at the Centre for Health Economics Research and Evaluation (CHERE) and the Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT). She has conducted research and evaluation projects with a range of government, NGO, industry and community partners. Irina has multidisciplinary expertise in the impact evaluation of non-medical intervention programs and services for populations with complex needs.
In 2019, Irina was awarded Atlantic Fellowship at the Global Brain Health Institute, Trinity College Dublin (Ireland), to join a unique cohort of leaders who are developing the critical skills and brain health knowledge to make transformative change around the globe.Irina is a Senior Research Fellow (honorary) with a joint appointment at the Centre for Health Economics Research and Evaluation (CHERE) and the Centre for Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT). She has conducted research and evaluation projects with a range of government, NGO, industry and community partners. Irina has multidisciplinary expertise in the impact evaluation of non-medical intervention programs and services for populations with complex needs.
In 2019, Irina was awarded Atlantic Fellowship at the Global Brain Health Institute, Trinity College Dublin (Ireland), to join a unique cohort of leaders who are developing the critical skills and brain health knowledge to make transformative change around the globe.- Academic
- Senior Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Senior Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Nancy Kong is a senior lecturer in the Centre for Health Economics Research and Evaluation (CHERE). She earned her PhD from Dalhousie University (Canada) in 2017. Nancy's expertise lies in leveraging microeconometric modeling to delve into the intricate connections between economics and health. Her research focus revolves around child development, with a particular emphasis on exploring how economic conditions are transmitted across generations, influencing children's health outcomes, cognitive abilities, and non-cognitive skills. Furthermore, Nancy is interested in the economics of innovation, especially the patent system and its implications for economic progress and technological advancements. Her research is covered by media outlets such as the New York Times, the Guardian, ABC News, and the Conversation.
Research interests:- Health inequality
- Socioeconomic determinants of health
- Maternal and child health
- Panel data analysis
- High dimensional data analysis
- Applied econometrics
Nancy Kong is a senior lecturer in the Centre for Health Economics Research and Evaluation (CHERE). She earned her PhD from Dalhousie University (Canada) in 2017. Nancy's expertise lies in leveraging microeconometric modeling to delve into the intricate connections between economics and health. Her research focus revolves around child development, with a particular emphasis on exploring how economic conditions are transmitted across generations, influencing children's health outcomes, cognitive abilities, and non-cognitive skills. Furthermore, Nancy is interested in the economics of innovation, especially the patent system and its implications for economic progress and technological advancements. Her research is covered by media outlets such as the New York Times, the Guardian, ABC News, and the Conversation.
Research interests:- Health inequality
- Socioeconomic determinants of health
- Maternal and child health
- Panel data analysis
- High dimensional data analysis
- Applied econometrics
- Academic
Disciplines- Applied economics
- Adjunct Associate Professor
- INSIGHT Cntr for Health Economics Research & Evaluation
- Adjunct Associate ProfessorINSIGHT Cntr for Health Economics Research & Evaluation
Tracey is an Associate Professor with the Centre for Health Economics Research and Evaluation (CHERE), a NHMRC Early Career (Sidney Sax) Fellow and registered pharmacist. Over the last 10 years, using an overarching health economics, drug utilisation and policy lens, Tracey has developed a vibrant research program that aims to improve health, especially among disadvantaged populations through better use of high-value medicines for non-communicable diseases.
Prior to joining CHERE, Tracey was a senior research fellow at The George Institute for Global Health, UNSW and the Menzies Centre for Health Policy, University of Sydney, and held an honorary postdoctoral research fellow appointment at The University of British Columbia, Canada where she spent two years establishing ongoing collaborations with leading health economists and pharmacoepidemiologists. She received her PhD from The University of Sydney (2014), was a University Medallist (BPharm, University of Sydney, 2004) and has worked as a clinical pharmacist in the hospital and community pharmacy settings as well as in pharmaceutical industry.
Tracey's expertise in health economics, clinical trial translation, and medication utilisation and policy research is recognised nationally: she is the first health economist elected onto the inaugural Professional Advisory Council to Asthma Australia, and the first person (outside the PBAC chair) to be an appointed member on both the drug utilisation and the economics subcommittees, which provide expert advice about drug utilisation and health economics to the Pharmaceutical Benefits Advisory Committee - Australia's world-leading Health Technology Assessment agency.Tracey is an Associate Professor with the Centre for Health Economics Research and Evaluation (CHERE), a NHMRC Early Career (Sidney Sax) Fellow and registered pharmacist. Over the last 10 years, using an overarching health economics, drug utilisation and policy lens, Tracey has developed a vibrant research program that aims to improve health, especially among disadvantaged populations through better use of high-value medicines for non-communicable diseases.
Prior to joining CHERE, Tracey was a senior research fellow at The George Institute for Global Health, UNSW and the Menzies Centre for Health Policy, University of Sydney, and held an honorary postdoctoral research fellow appointment at The University of British Columbia, Canada where she spent two years establishing ongoing collaborations with leading health economists and pharmacoepidemiologists. She received her PhD from The University of Sydney (2014), was a University Medallist (BPharm, University of Sydney, 2004) and has worked as a clinical pharmacist in the hospital and community pharmacy settings as well as in pharmaceutical industry.
Tracey's expertise in health economics, clinical trial translation, and medication utilisation and policy research is recognised nationally: she is the first health economist elected onto the inaugural Professional Advisory Council to Asthma Australia, and the first person (outside the PBAC chair) to be an appointed member on both the drug utilisation and the economics subcommittees, which provide expert advice about drug utilisation and health economics to the Pharmaceutical Benefits Advisory Committee - Australia's world-leading Health Technology Assessment agency.- Academic
- Masters Research or PhD student supervision
Disciplines- Applied economics
- Public health
- Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Milena joined CHERE as a Research Fellow in February 2018. She completed her Master of Health Economics at the University of Oslo. Prior to joining CHERE, Milena worked at MSD Norway, (a pharmaceutical Research and Development company), in the Policy and Communication group. Milena has held various roles in the Norwegian healthcare sector, both in the public and private sectors. Milena has worked on a range of different projects including development and adaptations of economic evaluations to support decision making, Health Technology Assessment of medical devices and surgical procedures as well development and implementation of eHealth initiatives. At CHERE Milena is a member of the Economic Evaluation team completing evaluations for the Pharmaceutical Benefits Advisory Committee (PBAC).Milena joined CHERE as a Research Fellow in February 2018. She completed her Master of Health Economics at the University of Oslo. Prior to joining CHERE, Milena worked at MSD Norway, (a pharmaceutical Research and Development company), in the Policy and Communication group. Milena has held various roles in the Norwegian healthcare sector, both in the public and private sectors. Milena has worked on a range of different projects including development and adaptations of economic evaluations to support decision making, Health Technology Assessment of medical devices and surgical procedures as well development and implementation of eHealth initiatives. At CHERE Milena is a member of the Economic Evaluation team completing evaluations for the Pharmaceutical Benefits Advisory Committee (PBAC).- Academic
Disciplines- Health economics
- Senior Research Fellow
- INSIGHT Cntr for Health Economics Research & Evaluation
- Senior Research FellowINSIGHT Cntr for Health Economics Research & Evaluation
Dr Dan Liu is a Senior Research Fellow at the Centre for Health Economics Research and Evaluation (CHERE). Prior to joining CHERE, she worked as a Research Fellow at the University of York in the United Kingdom. She has experience working at the World Health Organization (Switzerland) and Chinese Centre for Disease Control and Prevention (China). She holds a PhD in Economics from the Catholic University of the Sacred Heart (Italy).
Dr Liu has experience teaching Introductory Health Economics and STATA and supervising PhD students. Her primary research expertise lies in econometric modelling using large-scale patient-level data, and she has also contributed to projects involving economic evaluation. Her research interests include health policy and programme evaluation, competition policy and market structure, cancer care, mental health, digital health and climate change and health.
Dr Liu is an Editorial Board Member of BMC Health Services Research and serves as a Public Officer for the Australian Health Economics Society. She is currently a member of the UTS Low Risk Ethics Committee. Dr Liu was also part of the organising committee for the 2024 Australian Health Economics Society Conference and has served as a peer reviewer for the National Health and Medical Research Council (NHMRC) Ideas Grant scheme.
Dr Liu has been the recipient of multiple awards, including the Worldwide Universities Network (WUN) Research Mobility Programme Award, the WUN Research Development Fund Award, the Distilling Research Impact Award and the Faculty of Health Research Impact Competition Award.
Dr Dan Liu is a Senior Research Fellow at the Centre for Health Economics Research and Evaluation (CHERE). Prior to joining CHERE, she worked as a Research Fellow at the University of York in the United Kingdom. She has experience working at the World Health Organization (Switzerland) and Chinese Centre for Disease Control and Prevention (China). She holds a PhD in Economics from the Catholic University of the Sacred Heart (Italy).
Dr Liu has experience teaching Introductory Health Economics and STATA and supervising PhD students. Her primary research expertise lies in econometric modelling using large-scale patient-level data, and she has also contributed to projects involving economic evaluation. Her research interests include health policy and programme evaluation, competition policy and market structure, cancer care, mental health, digital health and climate change and health.
Dr Liu is an Editorial Board Member of BMC Health Services Research and serves as a Public Officer for the Australian Health Economics Society. She is currently a member of the UTS Low Risk Ethics Committee. Dr Liu was also part of the organising committee for the 2024 Australian Health Economics Society Conference and has served as a peer reviewer for the National Health and Medical Research Council (NHMRC) Ideas Grant scheme.
Dr Liu has been the recipient of multiple awards, including the Worldwide Universities Network (WUN) Research Mobility Programme Award, the WUN Research Development Fund Award, the Distilling Research Impact Award and the Faculty of Health Research Impact Competition Award.
- Academic
- Collaborative projects
- Membership of an advisory committee
- Join a web conference as a panellist or speaker
- Masters Research or PhD student supervision
- Teaching provision
Disciplines- Health economics
- Health policy
- Econometrics
- Public health
UTS Research Centre contact
- +61 2 9514 4720